(228 days)
No
The description focuses on the material properties and physical characteristics of a resorbable implant, with no mention of AI or ML for analysis, decision support, or any other function.
No.
Explanation: The device is a resorbable, macroporous implant in sheet form intended to maintain the relative position of weak bony tissue or for cement restriction in total joint arthroplasty procedures. Its function is primarily structural support and stabilization, not to provide therapy or treatment for a disease.
No
Explanation: The device is a resorbable, macroporous implant intended to maintain the relative position of weak bony tissue or for cement restriction. It is a therapeutic device used in surgical procedures, not a diagnostic tool that identifies or characterizes a disease or condition.
No
The device description clearly states it is a resorbable, macroporous implant in sheet form manufactured from polylactic acid (PLA), which is a physical material, not software.
Based on the provided text, the MacroPoreOS Protective Sheet is not an IVD (In Vitro Diagnostic) device.
Here's why:
- IVD Definition: In vitro diagnostic devices are used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information about a person's health.
- MacroPoreOS Protective Sheet Function: The description clearly states that the MacroPoreOS Protective Sheet is an implantable device intended to maintain the position of bony tissue or restrict cement during surgical procedures. It is a physical device used within the body, not for testing samples outside the body.
- Lack of IVD Characteristics: The description does not mention any testing of biological samples, analysis of biomarkers, or any other activity associated with in vitro diagnostics.
Therefore, the MacroPoreOS Protective Sheet is a surgical implant, not an IVD.
N/A
Intended Use / Indications for Use
The MacroPoreOS Protective Sheet is intended to maintain the relative position of weak bony tissue such as bone grafts, bone graft substitutes, or bone fragments from comminuted fractures. The MacroPoreOS Protective sheet is also indicated for cement restriction in total joint arthroplasty procedures.
Only when used in conjunction with traditional rigid fixation, the MacroPoreOS Protective Sheet is intended to maintain the relative position weak bony tissue in trauma and reconstructive orthopedic procedures involving:
- · Long bones
- · Flat bones
- · Short bones
- · Irregular bones
- · Appendicular skeleton
- · Thorax
When used alone (without traditional rigid fixation), the MacroPoreOS Protective Sheet is intended to maintain the relative position of bone graft substitutes in reconstructive orthopedic procedures involving:
- · Tumor resections where bone strength has not been compromised
- · Iliac crest harvests
This device is not intended for use in the spine. The device is not intended for load bearing indications unless used in conjunction with traditional rigid fixation.
Product codes (comma separated list FDA assigned to the subject device)
HRS, MAI, HWC
Device Description
MacroPoreOS Protective Sheet is a resorbable, macroporous implant in sheet form manufactured from polylactic acid (PLA). MacroPoreOS Protective Sheet can be cut with scissors to the desired shape and size. The MacroPore Power Pen can also be used to cut or shape the MacroPoreOS Protective Sheet to the desired shape or size. MacroPoreOS Protective Sheet is fully malleable when heated to approximately 65℃ (for example, by the use of sterile hot water), and thus can be conformed three dimensionally to most any anatomical orientation. The MacroPoreOS Protective Sheet can be rolled into a tube or used as a flat sheet. MacroPoreOS Protective Sheet can be used either alone or in conjunction with internal bone fixation devices such as plates and screws, which also can serve to further stabilize the anatomical region. The MacroPoreOS System includes MacroPoreOS Protective Sheets, a selection of resorbable MacroSorb Screws, MacroSorb Tacks and associated manual instruments.
MacroPoreOS Protective Sheet is provided in sheets of 20 x 20 mm to 120 x 120 mm and will be provided in other sizes as needed for particular surgical procedures. The pore size ranges from 500 microns to 2500 microns in diameter, with pores distributed uniformly throughout the sheet in an offset or aligned pattern. The thickness of the MacroPoreOS Protective Sheet ranges from 0.50 mm to 2.0 mm according to the orthopedic region to be treated, however, not to exceed a total mass of 18 grams.
The MacroPoreOS Protective Sheet is fabricated from polylactic acid (PLA).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
weak bony tissue such as bone grafts, bone graft substitutes, bone fragments from comminuted fractures, Long bones, Flat bones, Short bones, Irregular bones, Appendicular skeleton, Thorax, Iliac crest. Not intended for use in the spine.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
In Vitro Testing:
Because the MacroPoreOS Protective Sheet is intended to be heated in the surgical suite to temperatures above the material's glass transition temperature to facilitate shaping to anatomic structures, testing was performed to determine the effect of prolonged heating in saline at 60°C on inherent viscosity. The testing demonstrates that viscosity stayed within an appropriate range over 120 minutes. Therefore, the relatively brief exposure anticipated during the surgical preparation of MacroPoreOS Protective Sheet is not expected to have a significant effect on its mechanical properties.
Accelerated aging testing was performed on MacroPoreOS Protective Sheet. Testing demonstrated that the MacroPoreOS Protective Sheet is as rigid and as strong as the predicate after a simulated 6 month in vivo exposure. Furthermore, simulated in vivo accelerated testing indicates that the MacroPoreOS Protective Sheet retains all of its strength for the first 9 months and a steadily decrease in strength to zero after approximately 18 months.
Mechanical testing was performed on the MacroPoreOS Protective Sheet which determined the MacroPoreOS Protective Sheet to be substantially equivalent to the mechanical strengths of the predicate devices under indication for use conditions.
Crystallinity was tested for by DSC (differential scanning calorimetery). This test measures the amount of heat energy that is absorbed by a material. A crystalline material will require more energy once it of near it's melting point. This release of heat energy can be seen on a graph as a sharp spike and is referred to as a "melting endotherm". The tests ran on the sterile and non-sterile samples revealed no endothermic spikes. From this we verify the implants are amorphous or non-crystalline.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
K994158 Summary
MacroPoreOS Protective Sheet
Page 1 of 4
ADMINISTRATIVE INFORMATION
Manufacturer Name:
Official Contact:
MacroPore, Inc. 6740 Top Gun Street San Diego, CA 92121
Kenneth K. Kleinhenz Director of Regulatory Affairs Telephone (858) 458-0900 Fax (858) 458-0994
DEVICE NAME
Classification Name:
Trade/Proprietary Name:
MacroPoreOS Protective Sheet
Plate, Bone
ESTABLISHMENT REGISTRATION NUMBER 2031733
DEVICE CLASSIFICATION AND PRODUCT CODE
As shown in 21CFR 888.3030 Bone Fixation Appliances are intended for use in orthopedic procedures and are classified as Class II. Bone Plates have been assigned Product Code HRS.
INTENDED USE
The MacroPoreOS Protective Sheet is intended to maintain the relative position of weak bony tissue such as bone grafts, bone graft substitutes, or bone fragments from comminuted fractures. The MacroPoreOS Protective sheet is also indicated for cement restriction in total joint arthroplasty procedures.
Only when used in conjunction with traditional rigid fixation, the MacroPoreOS Protective Sheet is intended to maintain the relative position weak bony tissue in trauma and reconstructive orthopedic procedures involving:
- · Long bones
- Flat bones
- · Short bones
- · Irregular bones
- · Appendicular skeleton
- · Thorax
When used alone (without traditional rigid fixation), the MacroPoreOS Protective Sheet is intended to maintain the relative position of bone graft substitutes in reconstructive orthopedic procedures involving:
- · Tumor resections where bone strength has not been compromised
- · Iliac crest harvests
This device is not intended for use in the spine. The device is not intended for load bearing indications unless used in conjunction with traditional rigid fixation.
1
DEVICE DESCRIPTION
Design Characteristics
Design Charactive Sheet is a resorbable, macroporous implant in sheet form manufactured from polylactic acid (PLA). MacroPoreOS Protective Sheet can be cut with scissors to the desired shape and size. The MacroPore Power Pen can also be used to cut or shape the MacroPoreOS Protective Sheet to the desired shape or size. MacroPoreOS Protective Sheet is fully malleable when heated to approximately 65℃ (for example, by the use of sterile hot water), and thus can be conformed three dimensionally to most any anatomical orientation. The MacroPoreOS Protective Sheet can be rolled into a tube or used as a flat sheet. MacroPoreOS Protective Sheet can be used either alone or in conjunction with internal bone fixation devices such as plates and screws, which also can serve to further stabilize the anatomical region. The MacroPoreOS System includes MacroPoreOS Protective Sheets, a selection of resorbable MacroSorb Screws, MacroSorb Tacks and associated manual instruments.
MacroPoreOS Protective Sheet is provided in sheets of 20 x 20 mm to 120 x 120 mm and will be provided in other sizes as needed for particular surgical procedures. The pore size ranges from 500 microns to 2500 microns in diameter, with pores distributed uniformly throughout the sheet in an offset or aligned pattern. The thickness of the MacroPoreOS Protective Sheet ranges from 0.50 mm to 2.0 mm according to the orthopedic region to be treated, however, not to exceed a total mass of 18 grams.
Material Composition
The MacroPoreOS Protective Sheet is fabricated from polylactic acid (PLA).
In Vitro Testing
Because the MacroPoreOS Protective Sheet is intended to be heated in the surgical suite to temperatures above the material's glass transition temperature to facilitate shaping to anatomic structures, testing was performed to determine the effect of prolonged heating in saline at 60°C on inherent viscosity. The testing demonstrates that viscosity stayed within an appropriate range over 120 minutes. Therefore, the relatively brief exposure anticipated during the surgical preparation of MacroPoreOS Protective Sheet is not expected to have a significant effect on its mechanical properties.
Accelerated aging testing was performed on MacroPoreOS Protective Sheet. Testing demonstrated that the MacroPoreOS Protective Sheet is as rigid and as strong as the predicate after a simulated 6 month in vivo exposure. Furthermore, simulated in vivo accelerated testing indicates that the MacroPoreOS Protective Sheet retains all of its strength for the first 9 months and a steadily decrease in strength to zero after approximately 18 months.
Mechanical testing was performed on the MacroPoreOS Protective Sheet which determined the MacroPoreOS Protective Sheet to be substantially equivalent to the mechanical strengths of the predicate devices under indication for use conditions.
2
K994158 Summary
Crystallinity was tested for by DSC (differential scanning calorimetery). This test measures the amount Of heat energy that is absorbed by a material. A crystalline material will require more energy once it of near it's melting point. This release of heat energy can be seen on a graph as a sharp spike and is referred to as a "melting endotherm". The tests ran on the sterile and non-sterile samples revealed no endothermic spikes. From this we verify the implants are amorphous or non-crystalline.
EQUIVALENCE TO MARKETED PRODUCT
MacroSorbOS Protective Sheet shares indications and design principles with the following predicate device, which has been determined by FDA to be substantially equivalent to the following preamendment devices: Sofamar Danek Timesh (K974017).
Indications For Use
The MacroPoreOS Protective Sheet shares indications for use with the predicate device as both the I he Macrol oroon Trotective Sheet and the Timesh predicated for reinforcing weak bony tissue in orthopedic procedures. The MacroPoreOS Protective Sheet and the Timesh predicate also share cement restriction indication for use.
Design and Materials
Design and MacroSorbOS Protective Sheet and the predicate device (Sofamar Danek Timesh) are similar, consisting of a thin semi-rigid sheet with macroporosity. Both the predicate device I milesh) are similar, consistent ave a semi-rigid construction with pores of similar diameter and spacing. The pore size and spacing of the predicate device is within the pore size and spacing specifications of the MacroSorbOS Protective Sheet. The dimensions of the predicate device are also operiodions or the MacroSorbOS Protective sheet as both devices are provided in rectangular sheets that oompanders to the mechanical characteristics of the MacroSorbOS Protective Sheet are substantially equivalent to the predicate device with respect to initial and in vivo strengths and rigidity. In addition to physical characteristics, both the predicate device and the MacroSorbOS Protective Sheet can be cut to specific shapes and sizes by the end user. The titanium device differs from MacroSorbOS Protective Sheet device in that it may be left in place permanently or must be removed surgically, whereas the polymer devices are intended to be metabolized by the body and do not require removal.
3
| . .
- THE STORESSONATION
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|
| . | |
:
ત્તા
UMMARY : TABLE OF SUBSTANTIAL EQUIVALENCE
.
| Intended Use | Subject Device | Predicate Device | Related Device | |
|---|---|---|---|---|
| The MacroPoreOS Protective Sheet is | ||||
| intended to maintain the relative | ||||
| position of weak bony tissue such as | ||||
| bone grafts, bone graft substitutes, or | ||||
| bone fragments from comminuted | ||||
| fractures. The MacroPoreOS | ||||
| Protective sheet is also indicated for | ||||
| cement restriction in total joint | ||||
| arthroplasty procedures. Only when | ||||
| used in conjunction with traditional | ||||
| rigid fixation, the MacroPoreOS | ||||
| Protective Sheet is intended to | ||||
| maintain the relative position weak | ||||
| bony tissue in trauma and | ||||
| reconstructive orthopedic procedures | ||||
| involving: Long bones, Flat bones, | ||||
| Short bones, Irregular bones, | ||||
| Appendicular skeleton, Thorax. When | ||||
| used alone (without traditional rigid | ||||
| fixation), the MacroPoreOS Protective | ||||
| Sheet is intended to maintain the | ||||
| relative position of bone grafts or | ||||
| bone graft substitutes in reconstructive | ||||
| orthopedic procedures involving: | ||||
| Tumor resections where bone strength | ||||
| has not been compromised, Iliac crest | ||||
| harvests. This device is not intended | ||||
| for use in the spine. The device is not | ||||
| intended for load bearing indications | ||||
| unless used in conjunction with | ||||
| traditional rigid fixation. | MacroSorboS Protective | |||
| Sheet | Timesh (K974017) | |||
| Sofamar Danek | ||||
| For use in any oral-maxillo-cranio- | ||||
| facial surgical reconstructive | ||||
| procedure, either orthognathic or | ||||
| trauma, wherein rigid or semi-rigid | ||||
| internal fixation is utilized as a | ||||
| means of holding bone fragments | ||||
| together. Alternatively, the Timesh | ||||
| system is also indicated for use in | ||||
| reinforcing weak bony tissues in | ||||
| orthopaedic surgical procedures | ||||
| such as pelvic reconstructions, | ||||
| acetabular reconstruction, and | ||||
| cement restriction. This product is | ||||
| not intended for spinal use. | MacroPore Protective Sheet | |||
| (Protego System) | ||||
| (K972913) | ||||
| MacroPore Protective Sheet is | ||||
| intended for use in trauma and | ||||
| reconstructive procedures in the | ||||
| midface and craniofacial skeleton: |
- Comminuted fractures of the
naso-ethmoidal and infraorbital
areas 2. Comminuted fractures of
the frontal sinus wall 3. Trauma
of the midface or craniofacial
skeleton 4. Reconstructive
procedures of the midface or
craniofacial skeleton. The system
is not intended for use in the
mandible and/or for full load
bearing procedures. | MacroPore Protective Sheet
(K983360)
MacroPore Protective Sheet is
intended to facilitate healing in
trauma, reconstruction and bone
augmentation procedures of the
mandible. The following specific
indications are included: to
maintain the relative position of
bony fragments in trauma and
bone graft porcedures, and to
contain and prevent migration and
shifting of autograft, allograft
and/or bone graft substitutes that
may be necessary in
reconstructive procedures. |
| Design | Sheets of 0.50 - 2.0 mm
thickness, sizes 20 x 20 mm to
120 x 120 mm or as required. | Sheets of 0.2mm thickness,
size 76 x 45 mm. | Plates, screws and tacks of
various sizes. | Sheets of 0.50-2.0 mm
thickness, sizes 20 x 20 mm to
120 x 120 mm or as required. |
| Material | Poly (L-lactide-co-D,L-
lactide) 70:30, amorphous | Titanium | Poly (L-lactide-co-D,L-lactide)
70:30, amorphous | Poly (L-lactide-co-D,L-lactide)
70:30,
amorphous |
| Product Code | HRS | HRS | HRS and HWC | JEY |
.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around it. Inside the circle is an abstract symbol resembling a stylized human figure or bird in flight, composed of three curved lines.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 4 2000
Mr. Kenneth K. Kleinhenz Director of Regulatory Affairs MacroPore, Inc. 6740 Top Gun Street San Diego, California 92121
Re: K994158
Trade Name: MacroSorbOS Protective Sheet Regulatory Class: II Product Codes: HRS, MAI, HWC Dated: April 24, 2000 Received: April 25, 2000
Dear Mr. Kleinhenz:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
5
Page 2 - Mr. Kenneth K. Kleinhenz
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
ume R. bochner -
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Device Name: MacroPoreOS Protective Sheet
Indications for Use:
Indications for Use:
The MacroPoreOS Protective Sheet is intended to maintain the relative fromers, from was The MacrororeOS Protective Sheet is meanse substitutes, or bone fragments from a bony tissue such as bone graits, bone gran-sacething, and indicated for cement restriction in total joint arthroplasty procedures.
Only when used in conjunction with traditional rigid fration, the MacroPoreoSings in traves Only when is intended to maintain the relative position weak bony tissue in trauma and reconstructive orthopedic procedures involving:
- · Long bones
- · Flat bones
- Short bones
- · Irregular bones
- · Appendicular skeleton
- Thorax
When used alone (without traditional rigid fixation), the MacroPoreOS Protective Sheet When used alone (without traditional right and in the grafts or bone grafts substitutes in reconstructive orthopedic procedures involving:
- · Tumor resections where bone strength has not been compromised
- · Iliac crest harvests
This device is not intended for use in the spine. The device is not intended for load I mis device is nor meets used in conjunction with traditional rigid fixation.
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NECESSARY) 」 2 w = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
Concurrence of CDRH, Office of Device Evaluation (ODE)
X Prescription Use _
OR
Over-The-Counter Use
Mina R. lochner'
Division Sign Off
(Division Sign-Off) Division of General Restorative Devices K994158 510(k) Number_